Partner Fund Management »

Bio-Rad Laboratories shares owned by Partner Fund Management

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.1M 14k 293.61

More positions owned by Partner Fund Management

Ascendis Pharma A/s Ord Shs (ASND)
Axsome Therapeutics (AXSM)
Eli Lilly & Co. (LLY)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Humana (HUM)
UnitedHealth (UNH)
Neurocrine Biosciences (NBIX)
Inhibrx Biosciences (INBX)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Icon Pub SHS (ICLR)
Tenet Healthcare Corp Com New (THC)
Edwards Lifesciences (EW)
Waters Corporation (WAT)
Centene Corporation (CNC)

View all positions for Partner Fund Management

Top funds holding Bio-Rad Laboratories

First Eagle Investment Management
BlackRock
Dimensional Fund Advisors
Vanguard Capital Management
Ariel Investments
Vanguard Portfolio Management
Earnest Partners
State Street Corporation
Bank of America Corporation
Capital World Investors
Capital Research Global Investors
Ubs Global Asset Management Americas
First Pacific Advisors
Geode Capital Management
Nomura Holdings

View all funds holding Bio-Rad Laboratories